Daily roundup / Hapoalim investment advice under scrutiny
Kaman's deal to sell drugstore stake unravels while antidepressant Viepax continues to be in short supply.
Did Bank Hapoalim investment advisers give bad advice? The Israel Securities Authority suspects Bank Hapoalim investment advisers of urging clients to switch bond holdings, with the sole purpose of jacking up the bank's income from commissions on the trades. Certainly the switches, between one type of bond to another with similar features, made no sense for the clients and, if...
Like us on Facebook and get articles directly in your news feed